Literature DB >> 6438240

The identification of monoclonal class switch variants by sib selection and an ELISA assay.

G Spira, A Bargellesi, J L Teillaud, M D Scharff.   

Abstract

Monoclonal antibodies can now be generated against a wide variety of antigens. However, a potentially useful monoclonal antibody may be of the wrong class or subclass for a particular task. Antibodies of the desired class can be obtained by identifying rare subclones in which the variable region has been rearranged to a new constant region. We describe here the use of sib selection and an enzyme-linked immunoassay (ELISA) for isolating such class and subclass switch variants from 2 IgM and 1 IgG3 producing hybridoma. The relative simplicity of ELISA assays makes it feasible to apply this approach to many different hybridomas. Since commercial affinity purified class and subclass specific antibodies are now available, the method can be used by any laboratory. Furthermore, the technique does not require that the switch variants express surface immunoglobulin and enriches for hybridomas secreting higher amounts of antibody.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438240     DOI: 10.1016/0022-1759(84)90298-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

1.  Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.

Authors:  Solveig Klaebo Reitan; Kristian Hannestad
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Enhancing monoclonal antibodies and hybridoma cell lines.

Authors:  S S Seaver
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.

Authors:  G Spira; R R Pollock; A Bargellesi; M D Scharff
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

5.  Development of an anti-guinea pig CD4 monoclonal antibody for depletion of CD4+ T cells in vivo.

Authors:  Brianne N Banasik; Clarice L Perry; Celeste A Keith; Nigel Bourne; Hubert Schäfer; Gregg N Milligan
Journal:  J Immunol Methods       Date:  2019-08-14       Impact factor: 2.303

6.  Identification of mutant monoclonal antibodies with increased antigen binding.

Authors:  R R Pollock; D L French; M L Gefter; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Pollack; N L Koles; M J Preston; B J Brown; G B Pier
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies.

Authors:  Yumin Xia; Rahul D Pawar; Antonio S Nakouzi; Leal Herlitz; Anna Broder; Kui Liu; Beatrice Goilav; Manxia Fan; Ling Wang; Quan-Zhen Li; Arturo Casadevall; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-07-28       Impact factor: 7.094

10.  Molecular characterization of hybridoma subclones spontaneously switching at high frequencies in vitro.

Authors:  Maria D Iglesias-Ussel; Jiri Zavadil; Matthew D Scharff
Journal:  J Immunol Methods       Date:  2009-07-17       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.